Cantor Fitzgerald Reiterates Overweight Rating on Aclaris Therapeutis (ACRS): 2026 Rich in Catalysts Oct 15, 2025 07:13AM
Cantor Fitzgerald Upgrades Aclaris Therapeutis (ACRS) to Overweight Nov 20, 2024 03:46PM
Aclaris Therapeutics (ACRS) Sells OLUMIANT Royalties and Milestones to OMERS Life Sciences for Up to $31.5M Jul 16, 2024 04:03PM
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million Jul 16, 2024 04:01PM
Cantor Fitzgerald Reiterates Aclaris Therapeutis (ACRS) at Overweight, "Still a Lot of Value to be Unlocked in ACRS's Pipeline" Feb 24, 2022 09:20AM


Apr 6, 2021 11:02AM Aclaris Therapeutis (ACRS) PT Raised to $38 at Cantor Fitzgerald
Feb 22, 2021 12:33PM Aclaris Therapeutics (ACRS) Hires Bankers to Explore Potential Sale - Source
Jan 20, 2021 09:20AM Pre-Open Stock Movers 01/20: (APM) (EVLO) (NFLX) Higher; (GEVO) (HSTO) (BLRX) Lower (more...)
Jan 20, 2021 08:46AM Aclaris Therapeutics (ACRS) Prices 5.48M Share Common Stock Offering at $17.50/sh
Jan 20, 2021 08:45AM Aclaris Announces Pricing of Public Offering of Common Stock
Jan 19, 2021 05:44PM After-Hours Stock Movers 01/19: (NFLX) (CKPT) (PCAR) Higher; (HSTO) (BLRX) (ACRX) Lower (more...)
Jan 19, 2021 04:01PM Aclaris Therapeutics (ACRS) Announces Proposed Public Offering of Common Stock
Jan 19, 2021 04:01PM Aclaris Announces Proposed Public Offering of Common Stock
Jan 19, 2021 07:43AM Aclaris Therapeutis (ACRS) PT Raised to $15 at Cantor Fitzgerald; 'Data That Support Potential 1L, First-in-Class, Best-In-Class Drug for RA'
Oct 25, 2019 09:22AM UPDATE: Pre-Open Movers 10/25: (ACRS) (BOOM) (CHTR) Higher (VCRA) (PCG) (AMZN) Lower (more...)
Aug 9, 2019 09:08AM Aclaris Therapeutis (ACRS) PT Lowered to $5 at Cantor Fitzgerald
Jun 12, 2019 11:11AM Aclaris Therapeutis (ACRS) PT Lowered to $24 at Cantor Fitzgerald
Jul 9, 2018 09:19AM Cantor Fitzgerald Reiterates Outperform on Aclaris Therapeutics (ACRS) Following FDA Fast Track Designation
Mar 12, 2018 11:19AM Aclaris Therapeutis (ACRS): Eskata and Pipeline Should Drive Shares Higher - Cantor Fitzgerald
Jan 9, 2018 07:45AM Cantor Fitzgerald Reiterates Overweight on Aclaris Therapeutics (ACRS)
Aug 17, 2017 08:00AM Aclaris Therapeutics to Attend Upcoming Investor Conferences
Jun 15, 2017 04:44PM UPDATE: Cantor Fitzgerald Starts Aclaris Therapeutis (ACRS) at Overweight
Jul 5, 2016 08:39AM Aclaris Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference